HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 43 filers reported holding HARPOON THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $60,515 | -4.6% | 85,232 | 0.0% | 0.00% | – |
| Q1 2023 | $63,430 | -48.7% | 85,232 | -50.0% | 0.00% | – |
| Q4 2022 | $123,706 | +49.0% | 170,464 | +100.0% | 0.00% | – |
| Q3 2022 | $83,000 | -51.7% | 85,232 | -5.2% | 0.00% | – |
| Q2 2022 | $172,000 | -92.2% | 89,932 | -79.7% | 0.00% | – |
| Q1 2022 | $2,203,000 | -24.1% | 443,269 | +15.3% | 0.00% | – |
| Q4 2021 | $2,902,000 | -4.3% | 384,358 | +0.2% | 0.00% | – |
| Q3 2021 | $3,031,000 | -83.5% | 383,724 | -71.1% | 0.00% | -100.0% |
| Q2 2021 | $18,424,000 | +330.3% | 1,328,368 | +549.0% | 0.00% | – |
| Q1 2021 | $4,282,000 | +50.7% | 204,667 | +19.7% | 0.00% | – |
| Q4 2020 | $2,841,000 | -5.5% | 171,027 | -3.3% | 0.00% | – |
| Q3 2020 | $3,006,000 | +7.2% | 176,918 | +4.8% | 0.00% | – |
| Q2 2020 | $2,803,000 | +66.3% | 168,876 | +16.0% | 0.00% | – |
| Q1 2020 | $1,686,000 | -8.0% | 145,608 | +17.5% | 0.00% | – |
| Q4 2019 | $1,832,000 | +25.1% | 123,887 | +15.5% | 0.00% | – |
| Q3 2019 | $1,465,000 | +35.5% | 107,227 | +28.9% | 0.00% | – |
| Q2 2019 | $1,081,000 | – | 83,163 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,524,425 | $75,105,000 | 22.35% |
| MPM BioImpact LLC | 3,898,422 | $64,714,000 | 17.21% |
| New Leaf Venture Partners, L.L.C. | 2,921,405 | $48,495,000 | 13.92% |
| Avidity Partners Management LP | 1,206,351 | $20,025,000 | 1.28% |
| Consonance Capital Management LP | 844,162 | $14,013,000 | 0.84% |
| Orbimed Advisors | 1,835,704 | $30,473,000 | 0.43% |
| Artal Group S.A. | 900,000 | $14,940,000 | 0.42% |
| Cormorant Asset Management, LP | 645,257 | $10,711,000 | 0.41% |
| DAFNA Capital Management LLC | 85,119 | $1,413,000 | 0.41% |
| Soleus Capital Management, L.P. | 30,886 | $512,000 | 0.29% |